Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD)
CBD oil did not change symptom thresholds in patients, and there was no detectable effect on QOL or mood disorders.